Cash Flow Amylyx Pharmaceuticals, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-144.00
-302.00
54.00
-197.00
-87.00
-42.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-1.00
-45.00
-65.00
-1.00
4.00
2.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-123.00
-167.00
11.00
-179.00
-74.00
-36.00
Cash Flow from Investing Activities
14.00
75.00
92.00
-238.00
-46.00
0.00
Cash Flow from Financing Activities
257.00
0.00
3.00
431.00
158.00
46.00
Net Cash Inflow / Outflow
148.00
-92.00
107.00
12.00
37.00
9.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
1.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Amylyx Pharmaceuticals, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
-144.689
107.39
-251.00
-234.73%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-1.083
-194.537
193.00
99.44%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-123.343
-24.772
-99.00
-397.91%
Cash Flow from Investing Activities
14.039
13.799
1.00
1.74%
Cash Flow from Financing Activities
257.029
-89.729
346.00
386.45%
Net Cash Inflow / Outflow
148.799
-100.702
248.00
247.76%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
1.074
0
1.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 26.43% vs -1,506.55% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-123.34
-167.65
26.43%
Footer loading
